Publications
- Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Nivolumab as second-line therapy for patients with advanced NSCLC (non-small cell lung cancer)2022 | First Faculty of Medicine
- An ocular lesion of unknown aetiology2021 | First Faculty of Medicine
- Současné možnosti léčby ALK-pozitivního NSCLC2021 | First Faculty of Medicine
- What approach to ALK-positive NSCLC?2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Complete response to pembrolizumab in a patient with stage IV NSCLC (non-small cell lung cancer)2020 | First Faculty of Medicine
- Studie ALEX - současné postavení alektinibu v České republice (komentář)2020 | First Faculty of Medicine
- Rare case of choroidal metastasis in ALK-positive NSCLC that responds to crizotinib2019 | First Faculty of Medicine
- CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC)2023 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Komentář ke studii2023 | First Faculty of Medicine
Loading network view...